What a rewarding experience connecting with global biotech peers, researchers, and industry leaders at the 16th Annual World ADC San Diego 2025! The dynamic discussions around ADC innovation—from targeted conjugate technologies to commercial production challenges—reaffirmed our commitment to empower...

AsymBio team is heading to Antibody Engineering much more!

A Major Milestone for AsymBio: Shanghai Fengxian Commercial Production Base Is Officially Operational!We are thrilled to announce the official launch of our Shanghai Fengxian Commercial Production Base - our third core commercial hub alongside Jinshan and Zhangjiang, marking a game-changing leap for...

AsymBio is Thrilled to Join the 16th World ADC San Diego! Mark your calendars for Nov 3rd–6th, 2025. We will be at Booth #59 to showcase cutting-edge integrated solutions for your bioconjugates! Whether you’re tackling complex PD challenges or scaling up production, our experts are ready to collabor...

AsymBio is thrilled to join the 3rd ADC Process Development Summit in Boston—our first time at this industry-leading gathering focused on advancing antibody-drug conjugate (ADC) process innovation.Not only are we attending-we are proud to serve as a sponsor, too! This event is all about bringing tog...

Meet AsymBio at Festival of Biologics Basel. Connect with our experts and learn how our services can support your program at every stage!Location: Messe and Congress Center BaselBooth: 235Dates: Sep 30-Oct 2, 2025

Radiopharm Theranostics (ASX: RAD, Nasdag: RADXs Investigational New Drug (IND) application for Betabart (RV-01), its Lu177-B7H3 monoclonal antibody designed with strong affinity for the 4lg isoform of B7H3 that is highly expressed in tumors and not in healthy tissues.AsymBio, a strategic partner of...

Join AsymBio at the upcoming 3rd ADC Linker Conjugation Summit in Boston! Our team will be on site to discuss integrated CDMO solutions for payload-linkers and bioconjugates!

T-E Meds and Asymchem Laboratories successfully signed a strategic cooperation agreement. This partnership marks the beginning of a deep strategic collaboration in the field of innovative drug development, with the goal of jointly advancing the global pharmaceutical industry.Ms. Yang Rui, Co-CEO of ...

Join AsymBio at the BIO International Convention (Booth 1785) held in Boston Convention and Exhibition Center on June 16-19 to discuss how AsymBio can advance your molecules from early stage development to commercial manufacturing with our industry leading integrated CDMO solutions!